Plus Therapeutics Announces Presentation of Data from the ReSPECT™-GBM Trial and Plans for Treating Pediatric Brain Cancer

NEXT STORY
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CorMedix Inc. of Class Action Lawsuit and Upcoming Deadline – CRMD
PREV STORY
Editas Medicine Presents Data on New SLEEK Gene Editing Technology at Cold Spring Harbor Laboratory’s Genome Engineering: CRISPR Frontiers Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ScarX Therapeutics closes $2 million Series A financing

TORONTO, Feb. 16, 2016 (GLOBE NEWSWIRE) -- ScarX Therapeutics, a Canadian biotechnology company commercializing ...

author_avatar
NASDAQ Market News

Inova Personalized Health Accelerator Expands Precision Medicine Portfolio with Cyrano Therapeutic’s Novel Solution for Olfactory Impairment

New Nasal Spray Stimulates Olfactory Receptor Growth, Improving Sense of Smell and TasteFairfax, VA, ...

author_avatar
NASDAQ Market News

Medibio Enters Into an Agreement with Otsuka Pharmaceutical Development & Commercialization, Inc.

Medibio will leverage its proprietary Digital Mental Health platform to process Otsuka clinical data ...

author_avatar
NASDAQ Market News